Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

New Clinical Study Publication Validates Respiratory Outcomes for the Onera Home-polysomnography System

Contributed by: Business Wire

Logo

Business Wire logo

Images

Patient sleeps with the patient-applied Onera home Polysomnography (Onera hPSG) solution.
Patient sleeps with the patient-applied Onera home Polysomnography (Onera hPSG) solution.
Business Wire embedded0

Tags

Science
Biotechnology
Telemedicine/Virtual Medicine
Research
Health
Medical Devices
Health Technology
Clinical Trials
polysomnography

More Like This

A woman is conducting a sleep test (polysomnography) using the patch-based Onera STS hPSG system. (Photo: Business Wire)

Landmark Clinical Study Validates Patch-Based Onera Home-Polysomnography System in One of the Largest Sleep Diagnostic Trials of the Decade

A female patient is sleeping while undergoing a sleep study with Onera Health's home Polysomnography solution.

New Clinical Data Highlights Onera Health’s Patch-Based Home Polysomnography Solution at SLEEP 2025

Onera Sleep Test System (Onera STS): The innovative sensors of the patch-based Onera STS capture all signals required for a Polysomnography (PSG). (Photo: Business Wire)

Onera Presents New Clinical Data featuring the Innovative Onera STS at SLEEP 2024

Ruben de Francisco, Founder and CEO of Onera Health. (Photo: Business Wire)

Onera raises over €30M in Series C funding

Maria Sainz is the newly appointed Chair of the Board of Directors at Onera Health. (Photo: Business Wire)

Onera Health Appoints Maria Sainz as Chair of the Board

Business Wire logo

LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea

Business Wire logo

LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy

Business Wire logo

Signifier Medical Technologies Announces Upcoming Publication of Randomized Controlled Trial Results Examining High-Intensity (Active) Vs. Low-Intensity (Sham) Neuromuscular Electrical Stimulation in Patients for 6 Weeks

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us